A number of investment brokers have recently updated their price targets on shares of Bovie Medical Corporation (BVX). According to the latest broker reports outstanding on Monday 9th of May, 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 analysts “neutral”, 0 analysts “sell” and 0 analysts “strong sell”.

Most recent broker ratings

04/30/2015 – Bovie Medical Corporation had its “hold” rating reiterated by analysts at Zacks.

04/21/2015 – JMP Securities began new coverage on Bovie Medical Corporation giving the company a “outperform” rating. They now have a USD 5 price target on the stock.

04/15/2015 – Craig-Hallum began new coverage on Bovie Medical Corporation giving the company a “buy” rating. They now have a USD 4.5 price target on the stock.

04/29/2014 – Sidoti began new coverage on Bovie Medical Corporation giving the company a “buy” rating.

03/25/2014 – Bovie Medical Corporation was upgraded to “hold” by analysts at TheStreet.

The share price of Bovie Medical Corporation (BVX) was up +0.00% during the last day of trading, with a day high of 1.88. 8195 shares were traded during the last session.

The stock’s 50 day moving average is 1.76 and its 200 day moving average is 1.93. The stock’s market capitalization is 50.04M. Bovie Medical Corporation has a 52-week low of 1.60 and a 52-week high of 2.96.

View other investors thoughts on Bovie Medical Corporation with our new Stock Talk discussion platform. Sign up for free to contribute to the community and view research provided from other investors for any stock listed on the LSE, NYSE or NASDAQ.